1. Home
  2. EYPT vs MBUU Comparison

EYPT vs MBUU Comparison

Compare EYPT & MBUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • MBUU
  • Stock Information
  • Founded
  • EYPT 1987
  • MBUU 1982
  • Country
  • EYPT United States
  • MBUU United States
  • Employees
  • EYPT N/A
  • MBUU 2250
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • MBUU Marine Transportation
  • Sector
  • EYPT Industrials
  • MBUU Industrials
  • Exchange
  • EYPT Nasdaq
  • MBUU Nasdaq
  • Market Cap
  • EYPT 594.5M
  • MBUU 699.9M
  • IPO Year
  • EYPT 2005
  • MBUU 2014
  • Fundamental
  • Price
  • EYPT $7.48
  • MBUU $35.50
  • Analyst Decision
  • EYPT Strong Buy
  • MBUU Buy
  • Analyst Count
  • EYPT 8
  • MBUU 7
  • Target Price
  • EYPT $25.71
  • MBUU $42.17
  • AVG Volume (30 Days)
  • EYPT 922.9K
  • MBUU 149.4K
  • Earning Date
  • EYPT 03-06-2025
  • MBUU 01-28-2025
  • Dividend Yield
  • EYPT N/A
  • MBUU N/A
  • EPS Growth
  • EYPT N/A
  • MBUU N/A
  • EPS
  • EYPT N/A
  • MBUU N/A
  • Revenue
  • EYPT $45,713,000.00
  • MBUU $744,785,000.00
  • Revenue This Year
  • EYPT N/A
  • MBUU $4.07
  • Revenue Next Year
  • EYPT N/A
  • MBUU $10.12
  • P/E Ratio
  • EYPT N/A
  • MBUU N/A
  • Revenue Growth
  • EYPT 7.50
  • MBUU N/A
  • 52 Week Low
  • EYPT $6.90
  • MBUU $30.20
  • 52 Week High
  • EYPT $30.99
  • MBUU $54.31
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 44.49
  • MBUU 38.50
  • Support Level
  • EYPT $7.15
  • MBUU $34.61
  • Resistance Level
  • EYPT $8.25
  • MBUU $38.00
  • Average True Range (ATR)
  • EYPT 0.66
  • MBUU 1.10
  • MACD
  • EYPT -0.01
  • MBUU 0.08
  • Stochastic Oscillator
  • EYPT 22.01
  • MBUU 39.27

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About MBUU Malibu Boats Inc.

Malibu Boats is a leading designer and manufacturer of power boats in the United States. It is the market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a leading producer of sterndrive boats in the us in the 24- to 29-foot segment, in 2017 and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a leading seller of flat fishing boats, including bay, dual-console, and center-console boats. Malibu has also expanded into boat trailers and accessories and in 2020 began producing its own engines (Monsoon) for its performance sport boats and now for Cobalt. Malibu's target market includes a wide range of water enthusiasts who embrace the active outdoor lifestyle.

Share on Social Networks: